NEW YORK (GenomeWeb News) – Arcxis Biotechnologies said today that it will collaborate with Roche Molecular Systems, a business area of Roche Diagnostics, on sample-preparation technology for molecular diagnostics.
Under the collaboration, Arcxis will use its proprietary total RNA and genomic DNA isolation and concentration technology with PCR and RT-PCR-based diagnostic tests. The company expects that its methods for preparing blood and tissue will produce “significant performance benefits” for PCR-based tests.
Arcxis said the partnership offers an opportunity to apply its technologies to infectious disease and cancer detection tests.
“Many companies, large and small, have struggled to purify nucleic acids for molecular diagnostic tests. We believe that the application of our technology will extend the dynamic range of assays,” Jay West, Arcxis’ chief technology officer, said in a statement.